Reverse engineering antibiotic sensitivity in a multidrug-resistant Pseudomonas aeruginosa isolate

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 7, 2006, Pages 2506-2515

  Struble, Julie M ^a   Gill, Ryan T ^a  

^a UCB 450   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; BACTERIUM LIPOPOLYSACCHARIDE; CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; GENTAMICIN; KANAMYCIN; POLYMYXIN B; STREPTOMYCIN; TOBRAMYCIN; VERAPAMIL;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIUM ISOLATE; BIOENGINEERING; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; FOLLOW UP; GENE IDENTIFICATION; GENE MUTATION; MICROARRAY ANALYSIS; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVERSE ENGINEERING; RNA TRANSCRIPTION;

AMIKACIN; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENE EXPRESSION PROFILING; GENETIC ENGINEERING; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION; PSEUDOMONAS AERUGINOSA; TRANSCRIPTION, GENETIC;

EID: 33745629104     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01640-05     Document Type: Article

References (87)

1. Balows, A., and W. J. Hausler (ed.). 1991. Manual of clinical microbiology, 5th ed. ASM Press, Washington D.C.
2. Baughman, G. A., and S. R. Fahnestock. 1979. Chloramphenicol resistance mutation in Escherichia coli which maps in the major ribosomal protein gene cluster. J. Bacteriol. 137:1315-1323.
3. Belanger, M., L. L. Burrows, and J. S. Lam. 1999. Functional analysis of genes responsible for the synthesis of the B-band O antigen of Pseudomonas aeruginosa serotype O6 lipopolysaccharide. Microbiology 145(Pt 12):3505-3521.
4. Bert, F., and N. Lambert-Zechovsky. 1996. Comparative distribution of resistance patterns and serotypes in Pseudomonas aeruginosa isolates from intensive care units and other wards. J. Antimicrob. Chemother. 37:809-813.
5. Birdsell, D. C., and E. H. Cota-Robles. 1967. Production and ultrastructure of lysozyme and ethylenediaminetetraacetate-lysozyme spheroplasts of Escherichia coli. J. Bacteriol. 93:427-437.
6. Bolstad, B. M., R. A. Irizarry, M. Astrand, and T. P. Speed. 2003. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19:185-193.
7. Bryan, L. E., K. O'Hara, and S. Wong. 1984. Lipopolysaccharide changes in impermeability-type aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 26:250-255.
8. Burrows, L. L., D. F. Charter, and J. S. Lam. 1996. Molecular characterization of the Pseudomonas aeruginosa serotype O5 (PAO1) B-band lipopolysaccharide gene cluster. Mol. Microbiol. 22:481-495.
9. Cerda-Olmedo, E., P. C. Hanawalt, and N. Guerola. 1968. Mutagenesis of the replication point by nitrosoguanidine: map and pattern of replication of the Escherichia coli chromosome. J. Mol. Biol. 33:705-719.
10. Cetinkaya, Y., P. Falk, and C. Mayhall. 2000. Vancomycin-resistant enterococci. Clin. Microbiol. Rev. 13:686-707.
11. Choe, S. E., M. Boutros, A. M. Michelson, G. M. Church, and M. S. Halfon. 2005. Preferred analysis methods for Affymetrix GeneChips revealed by a wholly defined control dataset. Genome Biol. 6:R16.
12. Choudhuri, B. S., S. Bhakta, R. Barik, J. Basu, M. Kundu, and P. Chakrabarti. 2002. Overexpression and functional characterization of an ABC (ATP-binding cassette) transporter encoded by the genes drrA and drrB of Mycobacterium tuberculosis. Biochem. J. 367:279-285.
13. Chu, C., L. H. Su, C. H. Chu, S. Baucheron, A. Cloeckaert, and C. H. Chiu. 2005. Resistance to fluoroquinolones linked to gyrA and parC mutations and Overexpression of acrAB efflux pump in Salmonella enterica serotype Choleraesuis. Microb. Drug Resist. 11:248-253.
14. Cirz, R. T., J. K. Chin, D. R. Andes, V. de Crecy-Lagard, W. A. Craig, and F. E. Romesberg. 2005. Inhibition of mutation and combating the evolution of antibiotic resistance. PLoS Biol. 3:e176.
15. Crespo, M. P., N. Woodford, A. Sinclair, M. E. Kaufmann, J. Turton, J. Glover, J. D. Velez, C. R. Castaneda, M. Recalde, and D. M. Livermore. 2004. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-8, a novel metallo-β-lactamase, in a tertiary care center in Cali, Colombia. J. Clin. Microbiol. 42:5094-5101.
16. Davies, E. A., and M. R. Adams. 1994. Resistance of Listeria monocytogenes to the bacteriocin nisin. Int. J. Food Microbiol. 21:341-347.
17. Dean, C. R., C. V. Franklund, J. D. Relief, M. J. Coyne, Jr., K. Hatano, D. J. Evans, G. B. Pier, and J. B. Goldberg. 1999. Characterization of the serogroup O11 O-antigen locus of Pseudomonas aeruginosa PA103. J. Bacteriol. 181:4275-4284.
18. Eisen, M. B., P. T. Spellman, P. O. Brown, and D. Botstein. 1998. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA 95:14863-14868.
19. Fernandez-Moreno, M. A., L. Carbo, T. Cuesta, C. Vallin, and F. Malpartida. 1998. A silent ABC transporter isolated from Streptomyces rochei F20 induces multidrug resistance. J. Bacteriol. 180:4017-4023.
20. Fomsgaard, A., M. A. Freudenberg, and C. Galanos. 1990. Modification of the silver staining technique to detect lipopolysaccharide in polyacrylamide gels. J. Clin. Microbiol. 28:2627-2631.
21. Fung-Tomc, J., E. Huczko, M. Pearce, and R. E. Kessler. 1988. Frequency of in vitro resistance of Pseudomonas aeruginosa to cefepime, ceftazidime, and cefotaxime. Antimicrob. Agents Chemother. 32:1443-1445.
22. Galimand, M., T. Lambert, G. Gerbaud, and P. Courvalin. 1993. Characterization of the aac(6′)-Ib gene encoding an aminoglycoside 6′-N-acetyltransferase in Pseudomonas aeruginosa BM2656. Antimicrob. Agents Chemother. 37:1456-1462.
23. Garza-Ramos, G., L. Xiong, P. Zhong, and A. Mankin. 2001. Binding site of macrolide antibiotics on the ribosome: new resistance mutation identifies a specific interaction of ketolides with rRNA. J. Bacteriol. 183:6898-6907.
24. Guerola, N., J. L. Ingraham, and E. Cerda-Olmedo. 1971. Induction of closely linked multiple mutations by nitrosoguanidine. Nat. New Biol. 230:122-125.
25. Hancock, R. E., and F. S. Brinkman. 2002. Function of Pseudomonas porins in uptake and efflux. Annu. Rev. Microbiol. 56:17-38.
26. Hitchcock, P. J., and T. M. Brown. 1983. Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels. J. Bacteriol. 154:269-277.
27. Ho, I., C. Chan, and A. Cheng. 2000. Aminoglycoside resistance in Mycobacterium kansasii, M. avium-M. intracellulare, and M. fortuitum: are aminoglycoside-modifying enzymes responsible? Antimicrob. Agents Chemother. 44:39-42.
28. Hooper, D. C. 2001. Emerging mechanisms of fluoroquinolone resistance. Emerg. Infect. Dis. 7:337-341.
29. Huang, T. S., C. M. Kunin, S. Shin-Jung Lee, Y. S. Chen, H. Z. Tu, and Y. C. Liu. 2005. Trends in fluoroquinolone resistance of Mycobacterium tuberculosis complex in a Taiwanese medical centre: 1995-2003. J. Antimicrob. Chemother.
30. Hurley, J., G. Miller, and A. Smith. 1995. Mechanism of amikacin resistance in Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Diagn. Microbiol. Infect. Dis. 22:331-336.
31. Ikeno, S., Y. Yamane, Y. Ohishi, N. Kinoshita, M. Hamada, K. S. Tsuchiya, and M. Hori. 2000. ABC transporter genes, kasKLM, responsible for self-resistance of a kasugamycin producer strain. J. Antibiot. (Tokyo) 53:373-384.
32. Irizarry, R. A., B. M. Bolstad, F. Collin, L. M. Cope, B. Hobbs, and T. P. Speed. 2003. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 31:e15.
33. Irizarry, R. A., B. Hobbs, F. Collin, Y. D. Beazer-Barclay, K. J. Antonellis, U Scherf, and T. P. Speed. 2003. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4:249-264.
34. Jacoby, G. A., M. J. Blaser, P. Santanam, H. Hachler, F. H. Kayser, R. S. Hare, and G. H. Miller. 1990. Appearance of amikacin and tobramycin resistance due to 4′-aminoglycoside nucleotidyltransferase [ANT(4′)-II] in gram-negative pathogens. Antimicrob. Agents Chemother. 34:2381-2386.
35. Jonas, B. M., B. E. Murray, and G. M. Weinstock. 2001. Characterization of emeA, a norA homolog and multidrug resistance efflux pump, in Enterococcus faecalis. Antimicrob. Agents Chemother. 45:3574-3579.
36. Kado, C. I., and S. T. Liu. 1981. Rapid procedure for detection and isolation of large and small plasmids. J. Bacteriol. 145:1365-1373.
37. Kadry, A. A. 2003. Lack of efflux mechanism in a clinical isolate of Pseudomonas aeruginosa highly resistant to beta-lactams and imipenem. Folia Microbiol. (Praha) 48:529-533.
38. Kadurugamuwa, J., J. Lam, and T. Beveridge. 1993. Interaction of gentamicin with the A band and B band lipopolysaccharides of Pseudomonas aeruginosa and its possible lethal effect. Antimicrob. Agents Chemother. 37:715-721.
39. Kohler, T., M. Michea-Hamzehpour, P. Plesiat, A. L. Kahr, and J. C. Pechere. 1997. Differential selection of multidrug efflux systems by quinolones in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 41:2540-2543.
40. Kozovska, Z., and J. Subik. 2003. Screening for effectors that modify multidrug resistance in yeast. Int. J. Antimicrob. Agents 22:284-290.
41. Lambert, T., M. C. Ploy, and P. Courvalin. 1994. A spontaneous point mutation in the aac(6′)-Ib′ gene results in altered substrate specificity of aminoglycoside 6′-N-acetyltransferase of a Pseudomonas fluorescens strain. FEMS Microbiol. Lett. 115:297-304.
42. LeClerc, J. E., B. Li, W. L. Payne, and T. A. Cebula. 1996. High mutation frequencies among Escherichia coli and Salmonella pathogens. Science 274:1208-1211.
43. Leclercq, R. 2001. Safeguarding future antimicrobial options: strategies to minimize resistance. Clin. Microbiol. Infect. 7:18-23.
44. Lederberg, J., and E. M. Lederberg. 1952. Replica plating and indirect selection of bacterial mutants. J. Bacteriol. 63:399-406.
45. Lee, E. W., M. N. Huda, T. Kuroda, T. Mizushima, and T. Tsuchiya. 2003. EfrAB, an ABC multidrug efflux pump in Enterococcus faecalis. Antimicrob. Agents Chemother. 47:3733-3738.
46. Legakis, N. J., M. Aliferopoulou, J. Papavassiliou, and M. Papapetropoulou. 1982. Serotypes of Pseudomonas aeruginosa in clinical specimens in relation to antibiotic susceptibility. J. Clin. Microbiol. 16:458-463.
47. Li, X. Z., L. Zhang, and K. Poole. 1998. Role of the multidrug efflux systems of Pseudomonas aeruginosa in organic solvent tolerance. J. Bacteriol. 180:2987-2991.
48. Li, Y., T. Mima, Y. Komori, Y. Morita, T. Kuroda, T. Mizushima, and T. Tsuchiya. 2003. A new member of the tripartite multidrug efflux pumps, MexVW-OprM, in Pseudomonas aeruginosa. J. Antimicrob. Chemother. 52:572-575.
49. Livermore, D. M., T. G. Winstanley, and K. P. Shannon. 2001. Interpretative reading: recognizing the unusual and inferring resistance mechanisms from resistance phenotypes. J. Antimicrob. Chemother. 48(Suppl. 1):87-102.
50. Lomovskaya, O., A. Lee, K. Hoshino, H. Ishida, A. Mistry, M. Warren, E. Boyer, S. Chamberland, and V. Lee. 1999. Use of a genetic approach to evaluate the consequences of inhibition of efflux pumps in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 43:1340-1346.
51. Lomovskaya, O., M. Warren, A. Lee, J. Galazzo, R. Fronko, M. Lee, J. Blais, D. Cho, S. Chamberland, T. Renau, R. Leger, S. Hecker, W. Watkins, K. Hoshino, H. Ishida, and V. Lee. 2001. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob. Agents Chemother. 45:105-116.
52. Maloney, J., D. Rimland, D. Stephens, and A. Whitney. 1989. Analysis of amikacin-resistant Pseudomonas aeruginosa developing in patients receiving amikacin. Arch. Intern. Med. 149:630-640.
53. Miller, J. H. 1972. Experiments in molecular genetics. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
54. Mingeot-Leclercq, M. P., Y. Glupczynski, and P. M. Tulkens. 1999. Aminoglycosides: activity and resistance. Antimicrob. Agents Chemother. 43:727-737.
55. Moore, R. A., and R. E. Hancock. 1986. Involvement of outer membrane of Pseudomonas cepacia in aminoglycoside and polymyxin resistance. Antimicrob. Agents Chemother. 30:923-926.
56. Naas, T., L. Poirel, A. Karim, and P. Nordmann. 1999. Molecular characterization of In50, a class 1 integron encoding the gene for the extended-spectrum beta-lactamase VEB-1 in Pseudomonas aeruginosa. FEMS Microbiol. Lett. 176:411-419.
57. Naas, T., L. Poirel, and P. Nordmann. 1999. Molecular characterisation of In51, a class 1 integron containing a novel aminoglycoside adenylyltransferase gene cassette, aadA6, in Pseudomonas aeruginosa. Biochim. Biophys. Acta 1489:445-451.
58. National Committee for Clinical Laboratory Standards. 1990. Performance standards for antimicrobial disk susceptibility tests. Approved standard M2-A4, 4th ed. National Committee for Clinical Laboratory Standards, Villanova, Pa.
59. Neu, H. C., and L. A. Heppel. 1964. The release of ribonuclease into the medium when E. coli cells are converted to spheroplasts. Biochem. Biophys. Res. Commun. 14:109-112.
60. Nicas, T. I., and R. E. Hancock. 1983. Alteration of susceptibility to EDTA, polymyxin B and gentamicin in Pseudomonas aeruginosa by divalent cation regulation of outer membrane protein H1. J. Gen. Microbiol. 129:509-517.
61. Nicas, T. I., and R. E. Hancock. 1980. Outer membrane protein H1 of Pseudomonas aeruginosa: involvement in adaptive and mutational resistance to ethylenediaminetetraacetate, polymyxin B, and gentamicin. J. Bacteriol. 143:872-878.
62. Nikaido, H., and M. Vaara. 1985. Molecular basis of bacterial outer membrane permeability. Microbiol. Rev. 49:1-32.
63. Ochsner, U. A., P. J. Wilderman, A. I. Vasil, and M. L. Vasil. 2002. Gene-Chip expression analysis of the iron starvation response in Pseudomonas aeruginosa: identification of novel pyoverdine biosynthesis genes. Mol. Microbiol. 45:1277-1287.
64. Otto, M., and F. Gotz. 2001. ABC transporters of staphylococci. Res. Microbiol. 152:351-356.
65. Patzer, J., and D. Dzierzanowska. 1991. The resistance patterns and serotypes of Pseudomonas aeruginosa strains isolated from children. J. Antimicrob. Chemother. 28:869-875.
66. Pitt, T. L., D. M. Livermore, G. Miller, A. Vatopoulos, and N. J. Legakis. 1990. Resistance mechanisms of multiresistant serotype O12 Pseudomonas aeruginosa isolated in Europe. J. Antimicrob. Chemother. 26:319-328.
67. Poelarends, G. J., P. Mazurkiewicz, M. Putman, R. H. Cool, H. W. Veen, and W. N. Konings. 2000. An ABC-type multidrug transporter of Lactococcus lactis possesses an exceptionally broad substrate specificity. Drug Resist. Update 3:330-334.
68. Pumbwe, L., M. J. Everett, R. E. Hancock, and L. J. Piddock. 1996. Role of gyrA mutation and loss of OprF in the multiple antibiotic resistance phenotype of Pseudomonas aeruginosa G49. FEMS Microbiol. Lett. 143:25-28.
69. Pumbwe, L., and L. J. Piddock. 2000. Two efflux systems expressed simultaneously in multidrug-resistant Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 44:2861-2864.
70. Rahaman, S. O., J. Mukherjee, A. Chakrabarti, and S. Pal. 1998. Decreased membrane permeability in a polymyxin B-resistant Escherichia coli mutant exhibiting multiple resistance to beta-lactams as well as aminoglycosides. FEMS Microbiol. Lett. 161:249-254.
71. Ramos-Aires, J., P. Plesiat, L. Kocjancic-Curty, and T. Kohler. 2004. Selection of an antibiotic-hypersusceptible mutant of Pseudomonas aeruginosa: identification of the GlmR transcriptional regulator. Antimicrob. Agents Chemother. 48:843-851.
72. Raychaudhuri, S., J. M. Stuart, and R. B. Altman. 2000. Principal components analysis to summarize microarray experiments: application to sporulation time series. Pac. Symp. Biocomput. 2000:455-466.
73. Renau, T., R. Leger, E. Flamme, J. Sangalang, M. She, R. Yen, C. Ganno, D. Griffith, S. Chamberland, O. Lomovskaya, S. Hecker, V. Lee, T. Ohta, and K. Nakayama. 1999. Inhibitors of efflux pumps in Pseudomonas aeruginosa potentiate the activity of the fluoroquinolone antibacterial levofloxacin. J. Med. Chem. 42:4928-4931.
74. Saavedra, S., D. Vera, and C. Ramirez-Ronda. 1986. Susceptibility of aerobic gram-negative bacilli to aminoglycosides. Eifects of 45 months of amikacin as first-line aminoglycoside therapy. Am. J. Med. 80:65-70.
75. Sabtcheva, S., M. Galimand, G. Gerbaud, P. Courvalin, and T. Lambert. 2003. Aminoglycoside resistance gene ant(4′)-IIb of Pseudomonas aeruginosa BM4492, a clinical isolate from Bulgaria. Antimicrob. Agents Chemother. 47:1584-1588.
76. 3H-gentamicin and short-time bactericidal activity of gentamicin against Pseudomonas aeruginosa isolates with different lipopolysaccharide structures. Chemotherapy 45:296-302.
77. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
78. Shaw, K. J., H. Munayyer, P. N. Rather, R. S. Hare, and G. H. Miller. 1993. Nucleotide sequence analysis and DNA hybridization studies of the ant(4′)-IIa gene from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 37:708-714.
79. Shaw, K. J., P. N. Rather, R. S. Hare, and G. H. Miller. 1993. Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. Microbiol. Rev. 57:138-163.
80. Shervington, A., L. Abbasi, and S. Bdour. 2001. PCR detection of four genes encoding for aminoglycoside-modifying enzymes in bacteria of clinical isolates of Jordan University Hospital. World J. Microbiol. Biotechnol. 17:139-142.
81. Stover, C. K., X. Q. Pham, A. L. Erwin, S. D. Mizoguchi, P. Warrener, M. J. Hickey, F. S. Brinkman, W. O. Hufnagle, D. J. Kowalik, M. Lagrou, R. L. Garber, L. Goltry, E. Tolentino, S. Westbrock-Wadman, Y. Yuan, L. L. Brody, S. N. Coulter, K. R. Folger, A. Kas, K. Larbig, R. Lim, K. Smith, D. Spencer, G. K. Wong, Z. Wu, I. T. Paulsen, J. Reizer, M. H. Saier, R. E. Hancock, S. Lory, and M. V. Olson. 2000. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature 406:959-964.
82. Udo, E. E., and A. A. Dashti. 2000. Detection of genes encoding aminoglycoside-modifying enzymes in staphylococci by polymerase chain reaction and dot blot hybridization. Int. J. Antimicrob. Agents 13:273-279.
83. Vaara, M., T. Vaara, M. Jensen, I. Helander, M. Nurminen, E. T. Rietschel, and P. H. Makela. 1981. Characterization of the lipopolysaccharide from the polymyxin-resistant pmrA mutants of Salmonella typhimurium. FEBS Lett. 129:145-149.
84. Vanhoof, R., J. Content, E. Van Bossuyt, E. Nulens, P. Sonck, F. Depuydt, J. M. Hubrechts, P. Maes, and E. Hannecart-Pokorni. 1993. Use of the polymerase chain reaction (PCR) for the detection of aacA genes encoding aminoglycoside-6′-N-acetyltransferases in reference strains and gram-negative clinical isolates from two Belgium hospitals. J. Antimicrob. Chemother. 32:23-35.
85. White, R. 2002. Antibiotic resistance: where do ketolides fit? Pharmacotherapy 22:18S-29S.
86. Xiong, Y., J. Caillon, H. Drugeon, G. Potel, and D. Baron. 1996. Influence of pH on adaptive resistance of Pseudomonas aeruginosa to aminoglycosides and their postantiobiotic effects. Antimicrob. Agents Chemother. 40:35-39.
87. Zhao, Q., X. Z. Li, A. Mistry, R. Srikumar, L. Zhang, O. Lomovskaya, and K. Poole. 1998. Influence of the TonB energy-coupling protein on efflux-mediated multidrug resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 42:2225-2231.